Literature DB >> 4761607

Lymphoblastic response to autologous colon epithelial cells in ulcerative colitis in vitro.

P S Hunt, S Trotter.   

Abstract

The blastic transformation in vitro of peripheral blood lymphocytes was measured by the 72-hour uptake of tritiated thymidine ((3)H-6-thymidine) in 23 patients with mucosal ulcerative colitis, three patients with acute Crohn's colitis with rectal involvement, and seven normal subjects. The 23 patients with ulcerative colitis were subdivided into three groups, graded according to severity into seven with acute, severe, nine with active, chronic, and seven with quiescent disease. In the control cultures of lymphocytes without any added potential stimulant the uptake of (3)H-6-thymidine in the clinical subgroup of seven patients with acute, severe ulcerative colitis was significantly greater than in seven normal subjects (p<0.01). This contrasted with a reduced uptake of (3)H-6-thymidine by lymphocytes from seven patients with acute severe colitis when compared with seven normal subjects after stimulation with phytohaemagglutinin-P (PHA-P) (p<0.01). In further duplicate cultures of lymphocytes specifically stimulated by an equal number of viable autologous rectal epithelial cells, the uptake of (3)H-6-thymidine was significantly greater in seven patients with acute severe colitis when compared with seven normal subjects (p<0.01). The results in three patients with acute Crohn's colitis with rectal involvement showed no such evidence of lymphocyte sensitivity to autologous rectal epithelial cells and their uptake of (3)H-6-thymidine lay within the normal range.Evidence that the degree of lymphoblastic transformation was related to the clinical severity of ulcerative colitis was provided by the results obtained in the unstimulated and epithelial cell stimulant cultures. The uptake of (3)H-6-thymidine was directly related to the clinical severity of ulcerative colitis in the three subgroups studied. In addition, four of the seven patients with acute severe colitis were studied later in clinical remission. They were then found to have a significantly reduced uptake of (3)H-6-thymidine in response to autologous rectal epithelial cells (p < 0.01).

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4761607      PMCID: PMC1412840          DOI: 10.1136/gut.14.11.875

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

Review 1.  The cellular basis of immunological responses. A synthesis of some current views.

Authors:  I M Roitt; M F Greaves; G Torrigiani; J Brostoff; J H Playfair
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

Review 2.  Ulcerative colitis, autoimmune epiphenomena, and colonic cancer.

Authors:  B S Kronman
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

Review 3.  Ulcerative colitis 1970--recent developments.

Authors:  J B Kirsner
Journal:  Scand J Gastroenterol Suppl       Date:  1970

4.  Cell-mediated immune reaction to colon altered by bacteria.

Authors:  S Fink; R F Mais
Journal:  Gut       Date:  1968-12       Impact factor: 23.059

5.  Reactivity in vitro of lymphocytes from patients with ulcerative colitis.

Authors:  C F Hinz; P Perlmann; S Hammarström
Journal:  J Lab Clin Med       Date:  1967-11

6.  Inflammatory bowel disease. Cytophilic antibody and the cytotoxicity of lymphocytes for colonic cells in vitro.

Authors:  T G Shorter; K A Huizenga; R J Spencer; J Aas; S K Guy
Journal:  Am J Dig Dis       Date:  1971-08

7.  Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures.

Authors:  K Parent; J Barrett; I D Wilson
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

8.  Effect of E. coli antigens, tuberculin, and phytohaemagglutinin upon ulcerative colitis lymphocytes.

Authors:  S Stefani; S Fink
Journal:  Gut       Date:  1967-06       Impact factor: 23.059

9.  The autologous leukocyte skin test in patients with ulcerative colitis.

Authors:  D W Watson; H J Styler; R J Bolt
Journal:  Gastroenterology       Date:  1965-12       Impact factor: 22.682

10.  Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells.

Authors:  D W Watson; A Quigley; R J Bolt
Journal:  Gastroenterology       Date:  1966-12       Impact factor: 22.682

View more
  5 in total

1.  Decreased suppressor cell activity in inflammatory bowel disease.

Authors:  H J Hodgson; J R Wands; K J Isselbacher
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

2.  Immunological abnormalities involving the thymus in ulcerative colitis and therapeutic effects of thymectomy.

Authors:  M Tsuchiya
Journal:  Gastroenterol Jpn       Date:  1984-06

Review 3.  Idiopathic Inflammation Bowel Disease: is there a role for immunological mechanisms in etiopathogenesis?

Authors:  R G Shorter
Journal:  Gastroenterol Jpn       Date:  1982-10

4.  Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.

Authors:  S Meyers; D B Sacher; R N Taub; H D Janowitz
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

5.  Specificity of antibodies secreted by hybridomas generated from activated B cells in the mesenteric lymph nodes of patients with inflammatory bowel disease.

Authors:  L P Chao; J Steele; C Rodrigues; J Lennard-Jones; J L Stanford; C Spiliadis; G A Rook
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.